⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9144 | 0.95 | — | — | |
| SCHEMBL5309104 | 0.95 | — | — | |
| SCHEMBL11569432 | 0.90 | — | — | |
| SCHEMBL11693501 | 0.90 | — | — | |
| Iodide SCHEMBL10929544 | 0.90 | — | — | |
| SCHEMBL31375345 | 0.90 | — | — | |
| Hydrochloric Acid SCHEMBL646495 | 0.90 | — | — | |
| SCHEMBL11578198 | 0.90 | — | — | |
| SCHEMBL6790136 | 0.90 | — | — | |
| SCHEMBL8380640 | 0.90 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1080267-C | Preparation of intermediat of 19, 11 beta-bridge steroid | SCHERING AG (DE) | 2002-03-06 | — | — | CN | disclosed |
| CN-1061052-C | 11 Beta-aromatic group-4-estraene and acid additive salt application in medicine | SCHERING AG (DE) | 2001-01-24 | — | — | CN | disclosed |
| CN-1057770-C | Application of 19,11 beta-bridged sterodal compound in pharmaceutical working | SCHERING AG (DE) | 2000-10-25 | — | — | CN | disclosed |
| CN-1048499-C | 11 beta-aryl-4-estrene pharmaceutical composition and process for preparing same | SCHERING AG (DE) | 2000-01-19 | — | — | CN | disclosed |
| US-5843931-A | 6,7-modified 11β-aryl-4-oestrenes | SHERING AKTIENGESELLSCHAFT (DE) | 1998-12-01 | — | — | US | disclosed |
| CN-1039328-C | D-high-(16-ene)-11 beta-aryl-4-estrene, preparing process and application in medicine | SCHERING AG (DE) | 1998-07-29 | — | — | CN | disclosed |
| CN-1141926-A | Preparation of intermediat of 19, 11 beta-bridge steroid | SCHERING AG (DE) | 1997-02-05 | — | — | CN | disclosed |
| CN-1135488-A | Application of 19,11 beta-bridged sterodal compound in pharmaceutical working | SCHERING AG (DE) | 1996-11-13 | — | — | CN | disclosed |
| CN-1133296-A | 11 beta-aromatic group-4-estraene and acid additive salt application in medicine | SCHERING AG (DE) | 1996-10-16 | — | — | CN | disclosed |
| CN-1033033-C | 11 beta, 19 bridged steroids having progesterone antagonistic activity | SCHERING AG (DE) | 1996-10-16 | — | — | CN | disclosed |
| US-5426102-A | Antigestagenic, antiandrogenic, antiglucocorticoid, antimineralcorticoid properties | SCHERING AKTIENGESELLSCHAFT (DE) | 1995-06-20 | — | — | US | disclosed |
| CN-1074910-A | D-height-(16-alkene)-11 beta-aryl-4-estrenes, its preparation method and do the application of medicine | SCHERING AG (DE) | 1993-08-04 | — | — | CN | disclosed |
| CN-1048219-A | 11 beta-aryl-4-estrene pharmaceutical composition and process for preparing same | SCHERING AG (DE) | 1991-01-02 | — | — | CN | disclosed |
| CN-88102162-A | 19, 11 beta-bridged steroids, their production and pharmaceutical preparations thereof | — | 1988-11-23 | — | — | CN | disclosed |